Analytical Data
-
Gene name
PDCD2L
- Application
-
Alternative Names
PDCD2L; Programmed cell death protein 2-like
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BRP1
-
Expression Region
1-358aa
-
Molecular Weight
66.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDCD2L, or Programmed Cell Death 2-Like, is a protein belonging to the PDCD2 family, which is implicated in various cellular processes, including apoptosis and cell cycle regulation. Recent research has highlighted its potential role in cancer biology, particularly in how it may affect tumor growth and response to therapy. As a repressor, PDCD2L can influence gene expression by modulating transcription factors and other regulatory proteins, making it a significant factor in cellular homeostasis and regulatory networks. Studies have shown that PDCD2L expression levels can vary across different tissues and conditions, indicating its potential as a biomarker for certain diseases. The recombinant expression of PDCD2L proteins facilitates detailed functional studies, which are crucial for understanding its role in health and disease. By generating PDCD2L in a recombinant system, researchers can investigate its biochemical properties, interactions with other proteins, and functional outcomes in various cellular contexts. This knowledge could lead to the development of novel therapeutic strategies targeting PDCD2L or its pathways, offering new avenues for cancer treatment and improving our understanding of programmed cell death mechanisms.
